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Abstract
Background: The diagnosis of motor neurone disease (MND) is known to be challenging and there may be delay
in patients receiving a correct diagnosis. This study investigated the referral process for patients who had been
diagnosed with MND, and whether a newly-developed tool (The Red Flags checklist) might help General Practitioners
(GPs) in making referral decisions.
Methods: We carried out interviews with GPs who had recently referred a patient diagnosed with MND, and
interviews/surveys with GPs who had not recently referred a patient with suspected MND. We collected data
before the Red Flags checklist was introduced; and again one year later. We analysed the data to identify key
recurring themes.
Results: Forty two GPs took part in the study. The presence of fasciculation was the clinical feature that most
commonly led to consideration of a potential MND diagnosis. GPs perceived that their role was to make onward
referrals rather than attempting to make a diagnosis, and delays in correct diagnosis tended to occur at the
specialist level. A quarter of participants had some awareness of the newly-developed tool; most considered it
useful, if incorporated into existing systems.
Conclusions: While fasciculation is the most common symptom associated with MND, other bulbar, limb or respiratory
features, together with progression should be considered. There is a need for further research into how decision-support
tools should be designed and provided, in order to best assist GPs with referral decisions. There is also a need for further
work at the level of secondary care, in order that referrals made are re-directed appropriately.
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Background
Motor neurone disease (MND), which may also be
termed Amyotrophic Lateral Sclerosis (ALS), is one of
the most common neurodegenerative conditions of adult
life. There is an estimated annual incidence of 2 in
100,000, and prevalence of 5–7 per 100,000 in most
countries [1]. The disease causes progressive paralysis,
with typically a three to five year survival period following
diagnosis [2]. MND has varying forms of presentation,
with three recognised patterns of limb, bulbar or respira-
tory onset [3].
The diagnosis of MND has been described as being
often fraught with difficulties [4]. Clinical signs may
mimic several other neurological syndromes [5]. There
may be a failure to recognize the significance of symptoms
amongst patients, carers and primary and secondary care
health professionals [4]. For general practitioners (GPs),
this is in part due to the fact that most will only see one
or two cases in their career. One UK study reported a
mean time from onset to diagnosis of 16.2 months, with
delays due to incorrect diagnosis, not considering the
diagnosis, not identifying the symptoms as having a
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neurological cause, or referring to non-neurology spe-
cialist services [6].
The Motor Neurone Disease Association, in conjunc-
tion with The Royal College of General Practitioners and
specialist neurologists developed a Red Flag tool for
MND in 2014 (see Additional file 1). The tool was devel-
oped via a series of meetings of MND specialists. It com-
prises a checklist of symptoms that may indicate MND,
and was designed to respond to concerns regarding delays
in patients receiving specialist input. It was hoped that the
tool may improve timely referrals to neurology, and speed
up the time to accurate diagnosis [7].
Methods
The aim of the current study was to investigate the re-
ferral and subsequent journey of patients who are later
diagnosed with MND. We explored GP decision-making
processes, and whether the newly-developed checklist
for GPs might assist in optimal referral of patients with
muscle weakness.
We used qualitative interview methods and collected
data at two time points: prior to issuing of the Red Flags
toolkit; and a year following its introduction. We re-
cruited GPs who had referred a patient within the last
12 months who had been subsequently diagnosed with
MND, and those who had not. We used two methods of
recruitment. Firstly, contact details for GPs that had re-
cently referred, were provided by the regional MND cen-
tres, and they were invited to take part in telephone
interviews via letter. Secondly, recruitment was also
sought via an in-person approach at national and re-
gional GP events. During the second phase of the study,
we invited GPs at a training event (not related to neuro-
logical disorders) to complete a brief questionnaire to
supplement the interview data.
Ethics, consent and permissions
The study was performed in accordance with the Declar-
ation of Helsinki. It received ethical approval from the
School of Health and Related Research Ethical Commit-
tee at the University of Sheffield (reference 000884). An
information sheet was provided to participants prior to
their agreeing to be interviewed as part in the study. A
consent form was returned by post/email prior to the in-
terviews. The questionnaire contained brief information
about the study, with completion and return taken as
consent to participate.
Data collection and analysis
Semi-structured interviews were carried out over the tele-
phone by the first author, an experienced qualitative re-
searcher who had carried out previous studies in the field
of MND. Data were collected during the periods of
October 2013 to January 2014, and January to April 2015,
after publicising of the Motor Neurone Disease Associ-
ation (MNDA) Red Flag tool in early 2014. Participants
had no prior knowledge of the researcher. The semi-
structured content of the interviews was based on an
interview schedule which was piloted in one interview
before use. The 20–30 min interviews were recorded,
transcribed and analysed using techniques of thematic
analysis whereby interview transcripts are read line by line
and concepts (or themes) identified and assigned a code
[8]. Recorded data were deleted immediately following
transcription, and transcriptions were anonymised prior
to analysis. Data within each code were examined and
compared to develop a “tree” of themes and sub–themes
across the interviews. For example extracts describing
GPs use of websites were grouped and labelled as a
subtheme “sources of knowledge”, within the overarching
theme of “factors influencing differential diagnosis”.
Analysis was undertaken by the first author, emerging
themes were discussed with the second author, and drafts
were circulated to the Red Flags group for comment. Atlas.ti
software (version 7, Scientific Software Development) was
used to support the systematic process of data coding and
retrieval. The questionnaire used in phase two sought
information on awareness of the tool (Additional file 2).
Reporting of the study adheres to COREQ guidelines.
Results
Forty two GPs took part in the study. Figure 1 provides
an overview of the recruitment process. Eighteen were
interviewed before introduction of the tool and six were
interviewed at the second time point. We achieved a
19% response rate for participants who had recently re-
ferred (18 of 108 approached by letter). We are unable
to calculate a precise response rate for those who had
not referred, as we used our networks of contacts to re-
cruit, publicised the study at a national conference with
many hundreds of delegates, and many other events and
training where GPs were present, with limited success.
We estimate that the six participants were recruited
from several hundred approaches. Eighteen GPs at a
training event in Yorkshire (where there were 200–250
attendees) completed questionnaires at the second point
of data collection.
The sample consisted of 19 males and 23 females;
four with fewer than five years’ experience as a GP,
fourteen with five to ten years’ experience, and 23 with
more than ten years’ experience. Three GPs reported
that they had not seen any patients with MND during
their career, 23 estimated that they had seen one to
three patients, and 16 estimated that they had seen
more than three.
Analysis of the interview transcripts identified four
main themes in the data: uncertainty; symptoms of con-
cern; factors influencing differential diagnosis; and
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referral processes and systems (see Table 1). In the fol-
lowing paragraphs these themes and subthemes will be
described, with a number of illustrative quotes provided.
Uncertainty
The most common description of patients who had been
referred, or those that were likely to be referred by GPs
was of a patient who “just did not fit” any familiar
presentation:
I couldn’t make him fit any of my things I knew
something about. (GP4)
GPs described their feeling of uncertainty, a pattern
that they were unable to explain:
It didn’t add up and it wasn’t like ME. It was sort of
more intuitive I thought there’s something not right
here, very not right here. (GP2)
As a result of this uncertainty participants described a
tendency to categorise patients as a general “neurological
problem”. There was a recognition that limited know-
ledge of the disease meant that GPs relied on specialist
opinion. The priority was perceived to be referring the
patient on to the expert, rather than attempting to make
a differential diagnosis:
I felt I had to make the referral whatever, you know I
didn’t feel that the referral was going to be dependent
on seeking more information, I felt this is somebody
who needs to be seen. (GP6)
Participants reflected on whether MND had been at
the forefront of their mind when they had referred the
patient, in most cases it had not.
I was worried it was neurodegenerative. That much I
was aware of so that is something. I would love to say
the top of my list was MND, but I have to be honest
that it wasn’t. (GP4)
Symptoms of concern
Participants were asked to describe the main symptoms
that had either caused them concern, or would make
them concerned if seen in a patient. Participants identi-
fied fasciculation as the most common sign:
It was the fasciculation more than the weakness
obviously that was the real red flag to my mind. (GP5)
Fig. 1 The recruitment process
Table 1 Themes and subthemes in the data
Theme Subthemes
1. Uncertainty
2. Symptoms of concern Fasciculation
Progression
Speech disturbance
Lack of sensory involvement
Context
3. Factors influencing differential
diagnosis
Familiarity with patient
Influence of patient delay
Sources of GP knowledge
4. Referral processes and systems Discussion with patient
Referral pathways
Personal contact
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Disease progression was identified as a key symptom of
concern by eight participants:
Her story was not compatible with a stroke, it was
obviously one of sort of progressive weakness rather
than sudden weakness. (GP3)
Three GPs mentioned the presence of speech problems
as a trigger for neurology referral. This knowledge was
based on personal experience for two:
Speech in most cases that I’ve seen has been involved
very early on. (GP8)
Oh yes the other thing about this lady is that her
voice was a bit affected as well. No it wasn’t croaky it
was just that she hadn’t got such a strong voice.
(GP2)
Other participants did not include speech in their con-
sideration of possible symptoms, and one GP perceived
speech disturbance as a later onset feature:
Well I’d hope that it’d be diagnosed before they got
swallowing or speech problems. (GP15)
Two GPs highlighted that a lack of sensory involve-
ment would be important in the clinical pattern:
Yes I think it was just kind of very clear weakness was
the one thing without any sort of sensory problems as
well. (GP1)
One participant described the context of the pre-
senting symptoms as important in understanding the
overall picture:
It’d be the context of the muscle weakness so, it
would depend on the patient’s history, you know their
story of what had happened. (GP11)
Factors influencing differential diagnosis
Familiarity with the patient was highlighted as a poten-
tially important element in a GP’s ability to assess the
pattern of presentation and disease progression:
If you knew somebody you know what is different. I
don’t know if one of my colleagues had seen him
from that if they would have been as aware. (GP1)
GPs described four cases where there had been patient
delay seeking medical input, and this had made symp-
toms more noticeable. Patients had either described ex-
periencing symptoms for several months but did not
make an appointment, or had delayed making follow up
appointments following a consultation:
I think it would have been a very different situation if
it had been a patient presenting with early symptoms
that were quite vague. (GP10)
During the interviews we explored the sources of GP
knowledge about MND. While some participants de-
scribed having several patients with MND at their prac-
tice, for others their knowledge of MND was based on
their initial training:
I think Motor Neurone Disease had crossed my mind
because I had seen fasciculation and I think obviously
going back to medical school, that is the one thing
that you kind of tie with it. (GP14)
Participants were asked what resources they would use
if they had a patient with symptoms of muscle weakness.
Some GPs were unable to identify any resources, others
described using text books or speaking to colleagues.
The most commonly mentioned resources were online:
GP Notebook; patient.co.uk; or a general search using
Google:
I suppose, well I guess I would start looking online.
Looking up you know GP Notebook or something like
that…you know causes of a bulbar palsy. (GP4)
Participants were asked to describe any new resources
that would be helpful. While the majority were not able
to suggest any, one GP suggested the use of video clips
similar to YouTube, another a brief leaflet, and several
suggested embedding additional information in the re-
sources they were already using such as GP Notebook:
Just little 3–5 min video of one of the consultants or
registrars, or you know someone relatively charismatic
to do a little video with a patient and to video those
fasciculation’s….put it on something like a link, a lot
of us use something called GP notebook…you know a
link from there or other GPs use Mentor or links
from our computer systems. (GP15)
Referral processes and systems
GPs were asked about the content of their discussion
with the patient at the time of referral. There was some
variation in opinion regarding whether or not it was
preferable to mention the disease to patients prior to re-
ferral. Some patients had already researched MND on
the internet so GPs had been required to discuss the
disease. Participants described the challenge of having to
make a decision with the patient in front of them, their
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own lack of certainty, and also the potential impact of
mentioning MND to a patient:
I know most patients think Dignitas, euthanasia and
everything to do with motor neurone disease so I
didn’t want to send him into orbit. (GP2)
I said ‘I’m really worried about this because you know,
you’re getting worse and you shouldn’t be getting
worse if it’s a stroke and I think it might be something
else and I want you to be seen urgently’, I didn’t tell
him what I thought it might be. (GP9)
Two participants were concerned that referral to a
specialist MND clinic without a diagnosis, might be
traumatic for patients:
I think if I was going to refer them to the motor
neurone disease clinic I would tell them otherwise
they’d be sat in the waiting room thinking ‘what the
hell am I doing here?’ (GP15)
There are no examples in the data of GPs adopting or
advocating a “watch and wait” approach. Patients were
referred to specialists on first presentation of symptoms
perceived as worrying.
Of the 18 patients who had been recently referred by
participants, twelve had reportedly experienced convo-
luted referral pathways to specialist MND services. In
these cases MND had not been suspected by GPs, and
patients had been referred on to non-MND specialists. It
was typically at this point that incorrect diagnoses had
been made and inappropriate treatment commenced, or
patients had been referred from specialist to specialist
with no diagnosis.
Two patients had been referred to neurology and diag-
nosed as having had a transient ischaemic attack; and
one had been referred to neurology and then on to or-
thopaedics. Two patients had been referred to an Ear
Nose and Throat (ENT) specialist for suspected laryn-
geal problems, one of these was then referred on to
Speech and Language Therapy. One patient had been re-
ferred to a falls clinic and then on to physiotherapy; and
another directly for physiotherapy. One patient was re-
ferred to a muscular-skeletal service, another to a
neurophysiologist; one to orthopaedics, one was treated
by a private practitioner as having high cholesterol; and
the final patient had been referred initially to a
geriatrician:
So he then had an MRI of his head which showed a
small lesion on the left side which corresponded with
possibly some right sided symptoms, so he was told
he had a stroke. (GP12)
When I examined him I was concerned initially to
exclude something nasty on his larynx so I actually
sent him in a 2 week wait into ENT. (GP9)
He was put on a bit of a cocktail of cholesterol drugs
by somebody and was getting a lot of muscle
problems which I think clouded the symptoms he
had. (GP7)
For those patients referred to ENT, it was only when
speech became dysarthric, rather than dysphonic that
the diagnosis became questioned.
Two GPs mentioned the tendency for a diagnostic line
to be pursued once it had been started:
I think sort of reflecting back on it, it’s always just a
reminder to maybe ignore what’s gone before and
start with a clean piece of paper. (GP7)
There was some variation in the local referral systems
described by participants. Some reported that the system
required a general neurology referral which was then
triaged. There was frustration at the waiting time for
neurology appointments, and that it was not possible to
direct referrals to specific specialties:
You can’t do that through choose and book these
days, you have to refer generally. (GP4)
You put down urgent, they decide it’s not urgent or
vice versa. Once the appointment goes in, no matter
what’s on it, it’s reviewed, the hospital clinic, they
decide what happens. (GP8)
The benefit of personal contact via telephone with a
specialist was highlighted by several participants:
Unfortunately I’m sure like with a lot of areas of the
country we have great problems in getting urgent
neurology appointments. I actually phoned up the
local neurologist that I thought she was going to get
seen by. (GP6)
Awareness and views of the new Red flag MND tool
Six of the 24 participants at the second point of data col-
lection (12–15 months after its publication) had some
awareness of the new tool. One of these had been sent it
as part of a pack from the MNDA following a patient
diagnosis, one person had seen it in a magazine article,
two people had learned of it via word of mouth, and two
were unable to recall where they had heard of it. Of the
18 GPs who completed the questionnaire (which in-
cluded a copy of the checklist), eleven described it as
“useful”, “clear”, “easy to use” or “helpful”. One described
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it as useful although “they had lots of other similar
checklists”, another was concerned it would result in
over-referral of patients with muscle twitching, and one
perceived that it “had too many words, needs to be elec-
tronic”. Four did not comment on the format.
Interview participants highlighted that a limitation of
tools such as this, is that the diagnosis needs to be
already in the clinician’s mind to prompt its use. Given
its rarity, diagnoses other than MND may be considered
more readily.
Discussion
GPs described a range of symptoms which would
prompt them to consider MND as a diagnosis, with fas-
ciculation being the most common, and speech-related
symptoms least common. Other studies have reported
that patients with bulbar onset have a shorter mean time
from symptoms to diagnosis [5, 6]. It was interesting
therefore that speech-related symptoms were least fre-
quently mentioned as being associated with MND. The
GP role was perceived to be onward referral following
the recognition that something was not right, rather
than attempting to make a diagnosis. However, if the on-
ward referral was made to a non-MND service then de-
lays were incurred, as non-MND secondary care services
often did not identify MND. Many of our participants
described frustration with referral pathways which inhib-
ited selection of specialist services, with long waiting
times for neurology appointments.
Participants described relying on knowledge from
medical school, speaking to colleagues, or using websites
to access information. The use of the Red Flags checklist
to aid referral decision-making diagnosis was welcomed,
although only a quarter of our sample were aware of it.
The incorporation of checklists into existing systems
seems to be crucial to increase awareness and usage.
This study echoes earlier work in describing the often
challenging pathway for patients before a diagnosis of
MND is made [5, 6]. The findings highlight that it is fol-
lowing referral to non-MND specialist services that mis-
diagnosis/delays in diagnosis may often occur. A recent
paper which reconstructed the timelines of a patient
journey to a specialist multi-disciplinary clinic [9] reported
that the majority of patients were seen by a general practi-
tioner, and subsequently by neurology services. There was
an average of four contacts with health services and 4.8 in-
vestigations/tests, prior to their first Clinic visit.
A review of GP diagnosis and referral by the Kings
Fund [10] reported that the very low prevalence of cer-
tain conditions, and high degree of overlap in symptoms
for serious and common conditions, makes diagnosis in
primary care difficult. A tool that is easily accessible to
GPs to help direct referrals most appropriately, therefore
has potential value.
It has been estimated that an average GP would en-
counter a new case of MND once in their professional
lifetime [11]. This rarity of GPs encountering MND was
supported in our study, with just over half of the partici-
pants (23 of 42) estimating that they had seen between
one and three patients with MND during their career.
The Kings Fund review [9] suggested that the provision
of decision-support tools may be beneficial to GPs.
However, any paper-based checklist may be one of many,
filed away, or not easily retrieved, particularly when a
condition is rare.
A recent review of methods to manage referral between
GPs and hospital specialists across all patient groups,
identified inconsistent evidence for the use of guidelines
or decision-support tools having an impact on referral
practice [12]. The included studies evaluated use of guide-
lines for a range of conditions including dementia and
cancer. The review highlighted multiple elements that will
impact on the effectiveness of interventions aiming to
change GP referrals, including factors relating to the
doctor, the patient, and local processes and systems. Delay
in referral has been reported for other conditions [13–15].
A study evaluating a GP decision-support tool for cancer
diagnosis echoed our work in concluding that it could be
of value, although usability needed further consideration
[16]. Hill et al. highlighted that while referral guidelines in
all areas of medicine have proliferated, their effect has
sometimes been little evaluated [17].
Strengths and limitations
Recruitment of GPs proved challenging, with a low re-
sponse rate to initial approach and invitations, and large
drop out following initial agreement to participate. Our
final sample size, although small, is typical of qualitative
studies, and we were successful in achieving diversity in
terms of GP characteristics. We aimed to recruit more
equal numbers of those who had referred patients versus
those who had not referred. The relative rarity of the
condition reportedly influenced a reluctance to devote
valuable time to taking part in those who had not
referred. The survey increased the number of responses
from GPs who had not referred, although we acknow-
ledge that this was a small sample size from a single
region. Our sample may also contain a larger proportion
of GPs who had patients with convoluted referral routes
than is typical. GPs were keen to “tell the stories” of
patients who had experienced delay and distress, and
may have been more willing to volunteer to participate.
Conclusions
Fasciculation is the most common symptom GPs asso-
ciate with MND, and patients presenting with other
bulbar, limb or respiratory features may be referred to
non-MND specialist services, delaying correct diagnosis.
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A newly-developed checklist which includes a compre-
hensive list of potential signs has potential to be a useful
tool for GPs, although levels of awareness and usage need
to be enhanced by incorporating it into existing systems.
There is a need for further research into how decision-
support tools should be designed and provided, in order
to best assist GPs with referral decisions. There is also a
need for further work at the level of secondary care, in
order that referrals made are re-directed appropriately.
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